Hilton Beats Expectations on Heavy Demand for U.S. Vacations

(Bloomberg) — Hilton Worldwide Holdings Inc. reported better-than-expected results for the second quarter, as travelers made up for lost vacations.

  • The company reported adjusted earnings per share of 56 cents, according to a statement Thursday, beating the average analyst estimate of 39 cents. Its shares surged as much as 4.2%, the biggest intraday jump in more than five months.

Key Insights

  • Leisure travel surged in the U.S., which accounts for the largest share of Hilton’s revenue, helping push occupancy rates and room prices higher. Strong demand from vacationers offset sluggish corporate travel, helping U.S. hotels match pre-pandemic performance in recent weeks.
  • Revenue per available room, or Revpar, more than tripled from a year earlier, benefiting from a comparison to a period when global travel was locked down. Revpar was down 62% from the second quarter of 2019, before Covid-19 roiled global travel.
  • U.S. Room demand continued to improve in July even as Covid-cases spiked, Chief Executive Officer Christopher Nassetta said on a conference call with investors. With occupancy rates rising, labor availability remains a key issue, Nassetta said.
  • Still, the spread of the highly transmissible delta variant is threatening the travel rebound. Hilton is seeing a slower recovery in parts of the world with lower vaccination rates. Occupancy rates were 64% in the U.S., compared to 56% in Asia and 32% in Europe.

Market Reaction

  • Hilton shares jumped to $134.99 on Thursday in New York. The stock had gained 16% this year through Wednesday’s close, compared with a 2% gain for the Bloomberg Americas Lodging Index.

(Updates share price and adds CEO comments from earnings call.)

More stories like this are available on bloomberg.com

©2021 Bloomberg L.P.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

pcp
PCP Attribution Analysis
May 22, 2025

Dr. Sam Ambewadikar, RVP and Medical Director at Anthem National Accounts, joins Brent to unpack the power of primary care attribution analysis—a tool he helped pioneer to spotlight the clinical and financial impact of members not having an established PCP. Drawing from his background as a practicing pediatrician and claims analytics leader, Dr. Sam shares…

Read More
sydney health
Sydney Health Demo
May 22, 2025

In this episode, Christina Firouztash, Executive Advisor of Digital Solutions at Anthem, gives a dynamic walkthrough of the Sydney Health app—Anthem’s flagship digital member experience. Christina showcases how Sydney delivers personalized, simple, and equitable navigation across benefits, including virtual care, pharmacy, financial transparency, and social services access. From contextual chatbots and ID card access to…

Read More
pharmacy
Pharmacy Part 1
May 22, 2025

In this episode, Brent chats with Katie Brennan, National Sales Director at CarelonRx, about making pharmacy benefits more accessible, consistent, and member-friendly. Katie spotlights Carelon new advanced home delivery model, which brings the pharmacy counter—and the pharmacist—into the member’s home. With fewer retail pharmacies offering extended hours and many patients lacking reliable transportation, CarelonRx is…

Read More
inclusive care
Inclusive Care
May 22, 2025

Sammy Gonzalez, Regional Vice President at Elevance Health, joins Brent for a deeply personal and impactful conversation on health equity and inclusive care. Sammy shares a powerful story of medical misdiagnosis tied to cultural assumptions, underscoring how bias—even unintentional—can hinder care quality. He highlights Elevance’s work to improve diversity in provider networks, enhance cultural competency,…

Read More